| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/21/1999 | WO1999002140A1 Process for preparing fast dispersing solid oral dosage form |
| 01/21/1999 | WO1999002132A2 Use of submicron oil-in-water emulsions with dna vaccines |
| 01/21/1999 | WO1999002130A2 Storage-stable ophthalmic compositions comprising diclofenac and ofloxacin |
| 01/21/1999 | WO1999002120A2 Compositions and methods for reversibly increasing permeability of biomembranes |
| 01/21/1999 | WO1998043609A3 Chitosane microspheres |
| 01/21/1999 | CA2295976A1 Block copolymer |
| 01/21/1999 | CA2295860A1 Conjugates useful in the treatment of prostate cancer |
| 01/21/1999 | CA2295740A1 Use of submicron oil-in-water emulsions with dna vaccines |
| 01/21/1999 | CA2295375A1 Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 01/21/1999 | CA2295237A1 Antigen delivery system comprising monoglyceride or diglyceride derivatives as adjuvant |
| 01/21/1999 | CA2294865A1 Immunogenic lhrh compositions and methods relating thereto |
| 01/20/1999 | EP0891948A1 Aluminium oxide containing solid of high specific surface |
| 01/20/1999 | EP0891776A1 Simethicone/anhydrous calcium phosphate compositions |
| 01/20/1999 | EP0891191A1 Anti-tumour agent |
| 01/20/1999 | EP0891190A2 Method for enhancing the solubility of substantially water-insoluble compounds |
| 01/20/1999 | EP0855913A4 Iron dextran formulations |
| 01/20/1999 | EP0792288B1 Conjugates of bdnf and nt-3 with a water-soluble polymer |
| 01/20/1999 | EP0778775B1 Cosolvent parenteral formulation of tirilazad |
| 01/20/1999 | EP0774958B1 Vesicle formulation comprising non-ionic surfactant |
| 01/20/1999 | EP0689428B1 Enhanced circulation effector composition and method |
| 01/20/1999 | EP0655911B1 Ophthalmological preparation |
| 01/20/1999 | CN1205643A Dry compsns. |
| 01/20/1999 | CN1205641A Administration media for analygesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compsns. containing such media and drugs |
| 01/20/1999 | CN1205636A Injectable quinolone formulations |
| 01/20/1999 | CN1205632A Anti-helicobacter pylori agent |
| 01/20/1999 | CN1205629A Controlled release formulation for poorly soluble basic drugs |
| 01/20/1999 | CN1205628A Method and prepns. for stabilizing biological materials by drying methods without freezing |
| 01/20/1999 | CN1205613A Hybrid matrix implants and explants |
| 01/19/1999 | US5861440 Cosmetic and medicinal topical preparations |
| 01/19/1999 | US5861439 Method for enhanced electrotransport agent delivery |
| 01/19/1999 | US5861422 Agonist-antagonist combination to reduce the use of nicotine and other drugs |
| 01/19/1999 | US5861397 Piperazine based cytofectins |
| 01/19/1999 | US5861314 Genetic manipulation which comprises a liposome comprised of lipid material, and adeno-associated viral (aav) material for genomes |
| 01/19/1999 | US5861179 Treatment of epilepsy |
| 01/19/1999 | US5861174 Temperature sensitive gel for sustained delivery of protein drugs |
| 01/19/1999 | US5861173 Sustained release tablets with press coating on core of gel |
| 01/19/1999 | US5861171 Adeno-associated viral (AAV) liposomes and methods related thereto |
| 01/19/1999 | US5861159 Controlled release of pharmaceutically active substances for immunotherapy |
| 01/19/1999 | US5861156 Methods of delivering agents to target cells |
| 01/19/1999 | US5861149 Methods for wound treatment |
| 01/19/1999 | US5861141 Pharmaceutical formulations of cefaclor |
| 01/19/1999 | CA2207457C Coolant compositions |
| 01/19/1999 | CA2089820C Treatment of tumorigenic pathophysiological conditions with fgf-cytotoxic conjugates |
| 01/19/1999 | CA2073096C Phospholipid composition |
| 01/19/1999 | CA1340327C Mhc-mediated toxic conjugates useful in ameliorating autoimmunity |
| 01/14/1999 | WO1999001764A2 METHOD FOR DETERMINING GnRH RECEPTORS |
| 01/14/1999 | WO1999001579A1 Compositions and methods for the delivery of oligonucleotides via the alimentary canal |
| 01/14/1999 | WO1999001498A1 Conjugate of polyethylene glycol and chitosan |
| 01/14/1999 | WO1999001469A1 A method for attaching polyethylene glycol to macromolecules |
| 01/14/1999 | WO1999001463A2 Modified glycosides, compositions comprised thereof and methods of use thereof |
| 01/14/1999 | WO1999001146A1 Treatment of hemoglobin containing erythrocytes with nitric oxide |
| 01/14/1999 | WO1999001143A1 Cross-linked polysaccharide drug carrier |
| 01/14/1999 | WO1999001138A1 A pharmaceutical formulation of uridine triphosphate suitable for administration in a small volume |
| 01/14/1999 | WO1999001137A1 Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation |
| 01/14/1999 | WO1999001135A1 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine |
| 01/14/1999 | WO1999001133A1 Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin |
| 01/14/1999 | WO1999001122A1 Delayed-release dosage forms of sertraline |
| 01/14/1999 | WO1999001120A1 Solubilized sertraline compositions |
| 01/14/1999 | WO1999001118A2 Antioxidant enhancement of therapy for hyperproliferative conditions |
| 01/14/1999 | WO1999001116A1 Transdermal therapeutic system (tts) for administering sexual steroid hormones |
| 01/14/1999 | WO1999001115A1 Colon selective drug delivery composition |
| 01/14/1999 | WO1999001114A1 Prolonged anesthesia in joints and body spaces |
| 01/14/1999 | WO1999001112A1 Multiple unit effervescent dosage form |
| 01/14/1999 | WO1999001111A1 Stabilized sustained release tramadol formulations |
| 01/14/1999 | WO1999001110A1 Targeted liposomal constructs for diagnostic and therapeutic uses |
| 01/14/1999 | WO1999001109A2 Therapeutical system for transdermal delivery of levonorgestrel |
| 01/14/1999 | WO1999001108A1 Quick release compositions |
| 01/14/1999 | WO1998040498A3 Immunoadhesins and methods of production and use thereof |
| 01/14/1999 | WO1998039466A3 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof |
| 01/14/1999 | DE19729879A1 Lagerstabile ophthalmische Zusammensetzungen, umfassend Diclofenac und Ofloxacin A storage stable ophthalmic compositions comprising diclofenac and ofloxacin |
| 01/14/1999 | CA2295720A1 Transdermal therapeutic system (tts) for administering sexual steroid hormones |
| 01/14/1999 | CA2294988A1 Compositions and methods for the delivery of oligonucleotides via the alimentary canal |
| 01/14/1999 | CA2294900A1 Targeted liposomal constructs for diagnostic and therapeutic uses |
| 01/14/1999 | CA2264792A1 Treatment of hemoglobin containing erythrocytes with nitric oxide |
| 01/13/1999 | EP0890362A1 Compositions useful for transferring therapeutically active substances into a target cell, and their use in gene therapy |
| 01/13/1999 | EP0890359A1 Tablets containing beta-lactam antibiotic and process for producing the same |
| 01/13/1999 | EP0890357A2 Cosmetic and pharmaceutical compositions |
| 01/13/1999 | EP0889955A1 Recombinant phages |
| 01/13/1999 | EP0889944A1 PROCESS FOR STABILISING AND DISPERSING VEGETABLE OILS WHICH CONTAIN POLYUNSATURATED FATTY ACID RADICALS BY MEANS OF $g(g)-CYCLODEXTRIN |
| 01/13/1999 | EP0889926A1 Polymers containing cyclodextrin groups, process for their preparation and their use |
| 01/13/1999 | EP0889906A1 Amphipathic molecules as cholesterol and other lipid uptake inhibitors |
| 01/13/1999 | EP0889738A1 Microparticles, process for their production, and their use in ultrasound diagnosis |
| 01/13/1999 | EP0889737A1 Obesity protein compounds and formulations thereof |
| 01/13/1999 | EP0889736A1 Iscom or iscom-matrix comprising a mucus targetting substance and optionally, an antigen |
| 01/13/1999 | EP0889733A1 Stabilised growth hormone formulation and method of preparation thereof |
| 01/13/1999 | EP0889730A1 Pharmaceutical compositions of botulinum toxin or botulinum neurotoxin and methods of preparation |
| 01/13/1999 | CN1204965A Anion exchange resin-containing tablets |
| 01/13/1999 | CN1204960A Novel stable preparation use paracetamol as base and method for preparing same |
| 01/13/1999 | CN1204959A Solid delivery systems for controlled release of molecules incorporated therein and methods of making same |
| 01/13/1999 | CN1041600C Process for preparing polyisoprene compound having high content for soft capsules |
| 01/12/1999 | US5859221 Hybrid dna, rna; nuclease resistant |
| 01/12/1999 | US5859054 Leukotriene B4 derivatives, process for their production and their use as pharmaceutical agents |
| 01/12/1999 | US5859048 Containing active peptide or protein and tolmetin or salt thereof as mucosal absorption enhancer |
| 01/12/1999 | US5859023 Formulations and compositions of poorly water soluble camptothecin derivatives |
| 01/12/1999 | US5859022 Suspensions in n-methyl-2-pyrrolidinone; for administration to a patient with cancer |
| 01/12/1999 | US5858999 Cosolvent parenteral formulation of tirilazad |
| 01/12/1999 | US5858996 Acrylic polymer, amino tri(lower alkylene phosphonic acid) chelating agent; ophthalmic delivery |
| 01/12/1999 | US5858994 Carbohydrate conjugates as inhibitors of cell adhesion |
| 01/12/1999 | US5858993 Administering to accelerate wound healing, stimulate hair growth |
| 01/12/1999 | US5858784 Aerosol transfecting agent |